Trending

Biodegradable balloon spacers, BioProtect announces the launch of Clinical Trial followed by the FDA approval for Investigational Device Exemption in November , 2017 that seeks to…
Read More...

AstraZeneca declared that BYDUREON BCise was now available in pharmacies across the U.S. An injectable suspension 2mg sanctioned by the U.S FDA for adults afflicted with Type-2 Diabetes…
Read More...

Artificial intelligence imaging and workflow software, Viz.ai announced CE Mark of its Direct-to-intervention system, ContaCT that adopts to interpret brain CTs intimating a specialist…
Read More...

The developer of a rapid point-of-care diagnostics tests, DCN Dx declared the appointment of John L. Tokinson, Ph.D. as its Chief business development Officer, welcoming him on board.…
Read More...

Cofactor Genomics declared the results from a study undertaken by them and Fred Hutchinson Cancer Research Center slated for presentation at the Molecular Medicine Tri-Conference in…
Read More...

Clearbridge Biomedics announced successful registration of ClearCell® FX1 system, its target cell- enrichment device with the U.S FDA as a class I Medical device for to diagnose…
Read More...

GT Biopharma announces the successful completion of dosing in its phase 1 clinical trial for GTP-004 that claims to treat Myasthenia gravis. GTP-004 ensures safe administration of…
Read More...

Global standard platform for genomic data, Wuxi NextCode announced partnering with Rhythm to develop and commercialize therapies aimed to treat rare genetic disorders of obesity. Rhythm…
Read More...

Emotional Brain finally declares the successful Phase 2B results for its products Lybrido and Lybridos that were tested in 497 women suffering from Female sexual interest and Arousal…
Read More...

It is to be taken into account that Aerin Medical has been granted clearance for its novel non-invasive Airway Remodeling System termed as VIVAER to overcome nasal airway barriers thus…
Read More...

ESN group committed to natural skin care initiatives announced the rollout of its Ceramedx® brand of natural ceramide therapy products as a substitute for dry and sensitive skin. Earth…
Read More...

Aimmune Therapeutics announced its plans for the upcoming year to report top-line results in February from a pivotal phase 3 PALISADE trial of AR101 for peanut allergy following the…
Read More...

IT solutions to the global life sciences market, Instem announces the purchase of  Provantis preclinical software solution suite by  Guangdong Lewwin Pharmaceutical Research Institute…
Read More...

Octapharma USA declared Neil Herson to come on board to join as Senior VP of National Accounts and market access. Former ASD Healthcare, Neil possesses 25 years of global pharmaceutical…
Read More...

Biopharmaceutical company Kala pharmaceuticals into development and commercialization of product candidates incorporating the usage of MPP technology declared that the New drug…
Read More...

Harbour BioMed declared that it ventures into licensing agreement with BeiGene for producing human therapeutic monoclonal antibodies to a commercial-stage biopharmaceutical company that…
Read More...

U.S.-based multi platform gene therapy company pronounces completion of merger with Inotek pharmaceuticals that looks to combat rare diseases. The inclusive company to emphasize on…
Read More...

In a bid to replace its expired base shelf prospectus and corresponding shelf registration statement on form F-10, Aurinia Pharmaceuticals files new tentative base shelf prospectus …
Read More...

Committed to developing and commercialising products to cure rare diseases proclaims granting US patent entitled Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis.…
Read More...

PharmaMar enters into a distribution license agreement with Megapharm for the commercialisation of anticancer drug Aplidin (plitidepsin) in Israel derived from marine. As per the…
Read More...